---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-25-000084"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2025-05-21T23:59:59+00:00"
generated_at: "2026-05-20T22:35:53.783729+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BeiGene shareholders re-elect all director nominees and approve share issuance/repurchase mandates at AGM

## Summary
- Re-elected directors Hooper (956M for), Krishana (890M for), Wang (987M for), Yi (846M for), Sharp (985M for).
- Approved 20% share issuance mandate (718M for, 277M against) and 10% share repurchase mandate (995M for, 99K against).
- Approved Connected Person Placing Authorization for Amgen to maintain shareholding for up to 5 years, renewable annually.
- Ratified Ernst & Young as independent auditors for FY2025 (989M for, 6M against).
- Advisory say-on-pay passed with 875M for, 120M against.

## SEC filing metadata
- accession: 0001651308-25-000084
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2025-05-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130825000084/0001651308-25-000084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130825000084/bgne-20250521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-25-000084
- JSON: https://secwatch.observer/filing/0001651308-25-000084.json
- Plain text: https://secwatch.observer/filing/0001651308-25-000084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.